Make your money go further for just 25p per day

TyraTech (AIM: TYR) – well placed to launch a ‘bug attack’

03/03/2015 · Abbot Group (ABG)  · TyraTech Inc (TYR) 

We follow up on our AimZine article published last month, with more positive news from TyraTech.

Today this life sciences company, focusing on nature-derived insect and parasite control products, has announced that its Vamousse head lice products are to be listed by AmerisourceBergen, the second biggest distributor of pharmaceutical products in the USA. This agreement follows the recently announced listings for Vamousse obtained with McKesson and Cardinal Health, the number one and number three distributors of pharmaceutical products in the USA respectively.

These three distributors had an estimated combined sales…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Abbot Group

KBC Advanced Technologies plc (AIM:KBC) – nice contract award suggests life in oil and gas

11/09/2015 · Company Insights
The consultancy and software provider to the hydrocarbon industry has announced a material consulting contract award…

TyraTech (AIM: TYR) – well placed to launch a ‘bug attack’

03/03/2015 · Company Insights
We follow up on our AimZine article published last month, with more positive news from TyraTech.

More on TyraTech Inc

TyraTech (AIM: TYR) – well placed to launch a ‘bug attack’

03/03/2015 · Company Insights
We follow up on our AimZine article published last month, with more positive news from TyraTech.

The Ten Bagger Quest

12/02/2015 · Aimzine

High noon for bugs?
By Michael Crockett

There are 14 USA incorporated companies listed on AIM but most…


More Company Insights

Rocketing share price

Stonking Small Cap: still on the fast track!

24/04/2024

Poorly worded | Sector winner | Improving returns

Sign-up to our free email updates

SIGN UP